LyP-1-PEG350-DSPE
LyP-1-polyethylene glycol-1,2-Distearoyl-sn-glycero-3-phosphoethanolamine
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-C-3456 | 50mg | 1350.00 | + Add to cart |
|
| R-C-3456 | 100mg | 2100.00 | + Add to cart |
|
|
|
||||
Product description
Cyclopeptide LyP-1 modified liposomes:polypeptides as receptor targeted anti-tumor carrier are more and more used to improve the effect of chemotherapy drugs. It has also been proved by experiments that it can enhance the targeting specificity of drugs,enhance the targeted absorption of drugs,improve the anti-tumor effect,and at the same time,it can improve the original insoluble properties of some small molecule drugs.Peptide carrier targeting technology is known as a new generation of targeted drug development technology.
| Appearance | N/A |
|---|---|
| PEG Molecular Weight | 350 |
| purity | >95% |
| PDI by GPC | <1.5 |
| Solubility | N/A |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 3 weeks |
| Stability | 2 years |
Document
Related Product

Items-$0.00

Email:
Tel.:
msds----LyP-1-PEG350-DSPE
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


